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Abstract
 Objective—The purpose of this study was to explore communication barriers as independent 
predictors and potential mediators of variation in clinical recognition of diabetic peripheral 
neuropathy (DPN).
 Methods—In this cross-sectional analysis, we estimated the likelihood of having a DPN 
diagnosis among 4,436 patients with DPN symptoms. We controlled for symptom frequency, 
demographic and clinical characteristics, and visit frequency using a modified Poisson regression 
model. We then evaluated 4 communication barriers as independent predictors of clinical 
documentation and as possible mediators of racial/ethnic differences: difficulty speaking English, 
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not talking to one’s doctor about pain, limited health literacy, and reports of suboptimal patient-
provider communication.
 Results—Difficulty speaking English and not talking with one’s doctor about pain were 
independently associated with not having a diagnosis, though limited health literacy and 
suboptimal patient-provider communication were not. Limited English proficiency partially 
attenuated, but did not fully explain, racial/ethnic differences in clinical documentation among 
Chinese, Latino and Filipino patients.
 Conclusions—Providers should be encouraged to talk with their patients about DPN 
symptoms, and health systems should consider enhancing strategies to improve timely clinical 
recognition of DPN among patients who have difficult speaking English. More work is needed to 
understand persistent race/ethnic differences in diagnosis.
Diabetic distal peripheral neuropathy (DPN) is a common complication that affects over 5.5 
million people with diabetes and approximately 50% of people who have had diabetes for 10 
or more years.1 An estimated 20% of patients with DPN experience neuropathic symptoms, 
such as pain, a burning sensation, “pins and needles”, or numbness of both lower 
extremities.2 These symptoms are associated with lower quality of life, limited mobility, 
depression, and social dysfunction across the life course of patients with diabetes.2-6 While 
symptoms are often treatable and ameliorable, DPN is often under-diagnosed and 
undertreated in primary care settings.7
Clinicians rely on patient reports of symptoms, including pain type, severity, and impact on 
daily living, as well as diagnostic tests to diagnose symptomatic DPN.8 However, patients 
may be reluctant to report symptoms to their doctors due to the unusual nature and 
combination of symptoms (e.g., numbness, itching, tingling, crawling) and because of the 
competing demands of increasingly time-constrained primary care visits.9-12 Racial and 
ethnic minorities may be at increased risk for both underreporting of symptoms and under 
diagnosis of chronic pain conditions like DPN, particularly when language and other 
communication barriers are present. Specific communication barriers that contribute to these 
differences include limited language proficiency, inadequate health literacy and cultural 
beliefs that make some patients less likely to discuss pain symptoms.13,14
Research into variation in clinical detection of DPN among highly diverse cohorts or 
patients and communication factors that may explain such differences are needed. 
Identifying communication barriers that impede the clinical detection of DPN and their role 
as potential mediators of potential race/ethnic differences in pain reporting and outcomes is 
an important first step in improving detection and treatment. In this paper, we explore 
variation in clinical recognition of DPN symptoms, as indicated by the absence of a 
documented diagnosis of DPN in the electronic health record (EHR), and communication 
factors as independent predictors of this variation. We further evaluate whether the presence 
of communication barriers mediates variation in diagnosis by race or ethnicity.
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 Research Design and Methods
The setting for this study was Kaiser Permanente Northern California (KPNC), a large 
integrated health care delivery system serving more than 3 million people. This study was 
conducted as part of the Diabetes Study of Northern California (DISTANCE) and its 
ancillary, the Diabetes & Aging Study. DISTANCE surveyed a race-stratified, random 
sample of patients with diabetes to understand social disparities in diabetes care and 
outcomes.15
Data from DISTANCE were linked to clinical and administrative data from the Kaiser 
Permanente Diabetes Registry of Northern California, a database of Kaiser Permanente 
members diagnosed with diabetes since 1971 and the EHR at KPNC. Among the 20,188 
KPNC members who responded to the DISTANCE survey (response rate 62%), the sample 
was restricted to the five largest race/ethnicity subgroups (i.e., those who self-identified as 
African American or black, white, Chinese, Latino or Hispanic, or Filipino). Respondents 
with any lower extremity amputation were excluded due to the high probability that it was 
influenced by the condition of primary interest, DPN.1,2 Among the remaining 15,847 
respondents, 12,681 or 80% answered a question regarding the presence of DPN symptoms 
and their responses will be the focus of this analysis. This study focused on the 4,436 adult 
diabetes patients who reported having symptoms consistent with DPN on the survey.
 Outcome measure
The primary outcome of interest for this study was clinical documentation of DPN, defined 
as the presence of at least one inpatient or two outpatient diagnoses for peripheral 
neuropathy (ICD9: 356.0, 356.9, 357.2) in the medical record during the 24 months before 
or after the survey administration date.16 Also included were ICD 9 codes for related 
conditions that may mimic DPN in symptomatology, such as neuralgic amyotrophy, lesion 
of the plantar nerve, and neuralgia neuritis and radiculitis unspecified (ICD9: 250.60-250.63; 
337.0, 337.01, 337.1, 337.9, 349.9, 353.0, 353.1, 354.1, 354.8, 354.9, 355.0, 355.2, 355.3, 
355.4, 355,6, 355.79, 335.8, 335.9, 713.5, 723.4, 729.2). This dichotomous measure served 
as the primary outcome for the regression models.
 Measures of Communication Barriers
Barriers to patient-provider communication were assessed in four ways. First, the behavior 
of discussing pain with one’s doctor was represented by a survey question asking whether 
the patient discussed pain with their doctor in the prior 12 months. The question did not refer 
to DPN specifically, but to pain of any kind. Seventy one percent of patients with symptoms 
answered the following question: “During the past 12 months, have you ever discussed 
problems with pain with your doctor or health care provider?”
Second, an indicator of whether the patient reported difficulty communicating in English 
was included. This was measured based on a validated question asking if the patient had 
difficulty speaking or understanding English: always, often, sometimes, rarely or never). 
Eighty-five percent of patients with symptoms answered this question. Patients who 
answered always, often, or sometimes were categorized as having LEP.
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Third, health literacy was assessed based on a previously validated 3-item brief health 
literacy scale. From this scale, a single item, “How confident are you filling out medical 
forms by yourself?”, was used to assess health literacy.17-21 Specifically, patients were 
classified as having limited health literacy if they reported being somewhat, a little or not at 
all confident and health literate if they reported being quite a bit or extremely confident in 
their ability to understand health information. Previous publications using our study 
population have demonstrated the utility and validity of this scale in predicting outcomes 
that would be expected to be associated with inadequate health literacy.17,19, 21-24
Quality of patient-provider communication was assessed using the 4-point communication 
composite score for the well-known Consumer Assessment of Healthcare Providers and 
Systems (CAHPS) version 2.0 survey,25 based on patient responses to at least two out of 
four questions regarding the frequency with which their provider 1) listened carefully to 
what they had to say, 2) explained things in a way they could understand, 3) showed respect 
for what the patient had to say or 4) spent enough time with the patient. These questions 
were combined into a summary score with a best possible value of 100 and a minimum 
value of 0. For the 77% of subjects that answered these questions, we created a dichotomous 
indicator of communication quality to indicate optimal communication (i.e., score of 100) or 
suboptimal communication (i.e., score < 100). Three previous publications have 
demonstrated the utility and validity of these items and dichotomization of responses as 
worded in the DISTANCE survey in predicting outcomes that would be expected to be 
associated with patient-provider communication.17-19
 Race/Ethnicity
Race/ethnicity was the exposure of interest. Racial and ethnic subgroups were identified 
using self-reported categories from the DISTANCE survey: Chinese, African American, 
Latino/Hispanic, white or Filipino. Other racial and ethnic subgroups, including those 
reporting mixed race, were excluded due to small sample size.
 Potential mediators
 Clinical and Demographic Charcateristics—The frequency of DPN symptoms was 
assessed using a previously validated, single item question in the DISTANCE Survey: “Over 
the past 4 weeks, how often have you had pins and needles, numbness, burning or a tingling 
sensation in both your feet?”Response options regarding symptom frequency were: 5 to 7 
days a week; 3 to 4 days a week; 1 to 2 days a week; 1 to 3 days a month; or never or rarely. 
The statistical models predicting the likelihood of a diagnosis were restricted to those who 
reported having symptoms at least one day per month.
Clinical status was classified based on a combination of self-report and EHR data. Several 
measures of diabetes severity that are known risk factors for peripheral neuropathy were 
included:self-reported duration of diabetes in years (<5, 5-9, 10 years or more), an indicator 
for whether the last observed (prior to survey date) hemoglobin A1c (HbA1c) was greater 
than 9%, and evidence of any pharmacy dispensing of insulin. We controlled for BMI 
(underweight<18.5, overweight=25-30; obese>30) as recorded in the EHR, using normal 
weight (BMI=18.5-25) as the referent group. Also included was an indicator for whether the 
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total number of outpatient visits was above or below the median for all patients in the cohort 
to account for opportunities for diagnostic assessment and for possible competing demands 
for health care services.
Based on previous reports of a high degree of concurrent chronic pain and depression among 
patients with diabetes in our own5,6 and other26studies, an indicator for the presence of 
depressive symptoms reported in the survey was also included in the model. Depressive 
symptoms were defined as having a score of 10 or greater on the previously validated 8-item 
Patient Health Questionnaire depression scale (PHQ-8).27
Patients were classified into three age groups (<50, 50-65, 65+ years), sex, and educational 
achievement based on self-report (<high school graduate, high school graduate or 
equivalent, some college, college graduate).
 Statistical Analysis
Baseline differences in sociodemographic and clinical characteristics for patients with and 
without DPN symptoms were evaluated using t tests and chi-square tests. Among the subset 
reporting symptoms, the likelihood of clinical documentation of DPN as described above 
was assessed. Given that clinical documentation of DPN is not a rare event, we estimated a 
modified Poisson regression model to evaluate predictors of this dichotomous outcome.28 
The likelihood ratio statistic was used to assess model fit and multiple imputation to address 
missing covariates due to survey non-response to several categorical measures (e.g., 
difficulty understanding or speaking English).29 The multiple imputed data set (20 
imputations) was created using the multivariate normal model and Markov Chain Monte 
Carlo approach. Variables included in the model were the above described measures of 
patient demographic, clinical characteristics, and frequency of contact with the health care 
system.
Crude differences in detection by race and ethnicity were first evaluated. Next each of the 
communication barriers was separately added to the basic model to evaluate them as 
mediators of the race/ethnic differences and/or independent predictors of the outcome. Due 
to a high degree of correlation between the communication measures, we did not include 
them together in a single model. The impact of the inclusion of these measures to the basic 
model was assessed through evaluation of changes in the effect size and statistical 
significance of the other covariates to evaluate whether the communication measures 
explained variation in fixed attributes (i.e., race/ethnicity).30 Model fit was assessed using 
the Information Criterion.31
All statistical analyses were conducted in SAS v9.3.32 This study was approved by the 
Institutional Review Board at Kaiser Foundation Research Institute.
 Results
 Characteristics of Respondents with and without DPN Symptoms
Our cohort of 12,681 adult diabetes patients included: 31% self-identified as white, 8% 
Chinese, 22% African American or black, 24% Latino and 15% Filipino (Table 1). Most 
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patients (82%) were over the age of 50 and men and women were equally represented. 
Comparing patients with (4,436) and without (8,245) DPN symptoms, symptomatic patients 
were significantly more likely to be white, 50 or older, and less likely to have graduated 
college. Symptomatic patients had greater diabetes severity, including higher average BMI, 
longer duration of diabetes, a higher proportion of patients with A1c above 9.0%, and 
evidence of insulin use. Depressive symptoms were more commonly reported among 
symptomatic patients and they had a high average number of office visits. Patients with 
symptoms were also more likely to report inadequate health literacy (26.2% vs. 21.9%), and 
were more likely to talk with their doctor about pain (56.6% vs. 43.7%). Nearly half (46.2%) 
of patients reporting current symptoms had a diagnosis in the EHR compared to only 17% of 
those without current symptoms.
 Non-Communication Factors Associated with Clinical Documentation of DPN
Compared to whites, being Chinese [RR=0.66 (0.52,0.82))], Latino [RR=0.86 (0.77,0.95)], 
and Filipino [RR=0.68 (0.59,0.78)) were associated with a substantially lower likelihood of 
having a recorded diagnosis of DPN. Clinical recognition did not differ between African 
American [RR= 0.99 (0.91,1.07) and whites. Adjustment for all the communication factors 
and other potential mediators did not explain those observed differences; being Chinese [RR 
0.66 (0.52, 0.82)], Latino [RR 0.86 (0.77, 0.95)] and Filipino [RR 0.68 (0.59, 0.78)] were 
still associated with a reduced likelihood of having a recorded diagnosis.
Other patient level factors associated with having a recorded diagnosis included greater 
symptom frequency [3-4 days per week: Relative Risk 1.27 (95% Confidence Interval:1.10, 
1.48); 5-7 days per week: RR 1.62; (1.43, 1.83)], older age [50-64: RR 1.27 (1.10,1.47); 
65+: RR 1.46 (1.27, 1.71)], insulin use [RR1.15 (1.06, 1.25)], longer duration of diabetes 
[5-9 years: RR 1.16 (1.03,1.31); 10 years or more: RR 1.31 (1.17,1.47)], and more frequent 
physician visits [RR 1.41 (1.28, 1.55)] (Table 2).
 Communication Barriers as Independent Predictors of Variation
The results of our evaluation of the separate communication factors as independent 
predictors and as potential mediators of racial and ethnic differences are presented in Table 
3. Limited English language proficiency [RR 0.80 (0.68, 0.94)] and not talking with one’s 
doctor about pain [RR 0.82 (0.73, 0.93)] were independently associated with the absence of 
clinical documentation. We found no evidence of an independent relationship between 
health literacy and patient-reported quality of communication with the physician on 
documentation of DPN.
 Communication Barriers as Mediators of Racial/Ethnic Differences in Diagnosis
Adjustment for these communication factors did not substantively attenuate the above 
described variation by race/ethnicity, with the exception of language proficiency. 
Specifically, the effects of Chinese, Latino and Filipino race/ethnicity trended toward the 
null after adjustment for this factor. We also tested for, but did not find evidence of, 
interactions between race/ethnicity and the communication factors on DPN documentation.
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In a diverse cohort of diabetes patients, 35% (N=4,436) reported having symptoms 
indicating distal diabetic peripheral neuropathy. Diabetes patients with DPN symptoms had 
higher BMI and more outpatient visits relative to those without symptoms, which was 
similar to a previous study in a similar setting.33 DPN was clinically documented in the 
EHR for nearly half of patients who reported symptoms. Chinese, Filipino, and Latino were 
significantly less likely to have clinical documentation of DPN.
Low English language proficiency was independently associated with the absence of clinical 
documentation, as was not talking with one’s doctor about pain. While English proficiency 
slightly attenuated racial and ethnic differences in diagnosis, neither of these communication 
factors fully explained differences in DPN documentation by race/ethnicity. At the time 
these data were collected, interpreter and translation services were available in this setting, 
including in person services, phone services, and translated educational materials. However, 
additional services and programs related to the qualification of bilingual staff and the 
implementation of real-time interpreter services via remote video have been implemented in 
recent years.34
In addition to identifying substantive race/ethnic differences, these findings suggest that 
some, but not all communication factors may influence the likelihood of clinical recognition 
of DPN across subgroups. For example, we did not find an association between patient-
reported communication quality and clinical documentation of DPN. A previous study using 
data from the DISTANCE survey found a positive association between patient-provider 
communication and medication adherence among diabetes patients.19 Our findings may 
suggest that the quality of communication has a different and potentially larger impact post-
diagnosis than on the likelihood of clinical recognition of DPN.19 Clinical risk factors such 
as symptom frequency and the frequency of physician visits were more strongly associated 
with the outcome, suggesting that diseases that require a patient to tell the story may be 
under-detected relative to those that manifest in ways that are obvious to the clinician (e.g., 
physical signs).
This may be the first study to show differences in rates of clinical recognition of DPN by 
race and ethnicity. In particular, our finding of substantially lower rates of clinical 
recognition of DPN among Chinese, Latino and Filipino patients was enabled by the highly 
diverse nature of the DISTANCE cohort. However, the included communication barriers, 
some of which were modestly predictive, failed to explain observed differences in diagnosis 
by patient attributes of race/ethnicity. Moreover, no evidence of interaction effects was 
found, suggesting there may be other, unobserved factors that account for the social or 
cultural differences in detection of DPN.
Several study limitations should be taken into account. Causal inferences are not possible 
given the cross sectional design. The absence of a recorded clinical diagnosis in the EHR 
may reflect a failure to record, but not necessarily a failure to detect diabetic peripheral 
neuropathy. This measurement error may have caused us to underestimate rates of detection, 
but should not bias our estimates of the differential effect of social factors and 
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communication on the likelihood of having a recorded diagnosis if failure to diagnose is 
similar across patient characteristics. While it is possible that some patients reporting DPN-
like symptoms actually had other co-occurring pain conditions such as arthritis, the 
similarity of our symptom-based prevalence estimate to other reports of DPN suggest that 
such misattribution was rare. In addition, a conservative approach of including several 
additional ICD 9 codes to cover conditions that may have a similar presentation to DPN was 
employed. Similarly, DPN could be present in the absence of any patient awareness (e.g., 
numbness only) and this may impact the likelihood of clinical recognition and may differ by 
race/ethnicity.
Multiple imputation was used to account for missing data with the knowledge that the 
likelihood of missing covariates may have been related to patient characteristics and the 
likelihood of the outcome. These results were robust to sensitivity analyses that included 
modeling in a missing category and use of complete case analysis. However, the analysis did 
not control for possible non-response bias in communication related questions in the 
DISTANCE survey in which patients who elected not to answer questions about 
communication may have been systematically different in statistically significant ways. In 
addition, patients may have received a diagnosis outside our window of observation of two 
years before and after the symptom report. However, reliance on an EHR and the stable 
nature of this Kaiser membership make it less likely that diagnoses were missed.
Finally, because the data used were not explicitly collected for the purpose of identifying 
predictors of DPN, the models could not directly specify the temporal relationships between 
the communication variables (e.g., communicating with one’s doctor about pain) and the 
diagnosis of DPN.
 Conclusions
Health care costs attributed to DPN are estimated to be between $5 and $15 billion per year, 
accounting for nearly one-third of all diabetes related costs.1 While DPN is not curable, 
progression can be slowed through improved glycemic control 3,35 and long term impact 
may be reduced through the effective treatment of symptoms.36,37 Untreated symptoms are 
associated with higher health services use and costs among patients with DPN.2,3,36 In 
addition, patients with distal DPN are at a much greater risk of lower extremity infection and 
amputation.38
These findings suggest that strategies to improve DPN recognition and treatment should be 
sensitive to both communication barriers and potential under-recognition of DPN among 
Chinese, Latinos and Filipino patients. Health systems should explore opportunities to 
reduce gaps in communication, specifically enhancing the propensity of patients to discuss 
pain, and alleviating language barriers between patients and providers. Competing demands 
in the clinic setting may impede efforts to collect information about DPN or its symptoms 
during routine visits.39 To address this challenge, the health care system in which this study 
was conducted recently instituted routine screening of diabetes patients for DPN by medical 
assistants while patients wait for a doctors’ appointment. Alternatively, several studies have 
reported success in the use of patient-focused technology (e.g., interactive voice response, 
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web portals) to facilitate gathering of information on patient symptoms between physician 
visits across diverse patient populations, including those who do not speak English.40 Two of 
the authors (ASA, MJ) are conducting a cluster randomized controlled trial funded by the 
Patient Centered Outcome Research Institute (www.pcori.gov) to test the effectiveness of 
collectinginformation about DPN symptoms and treatment experiences directly from 
patients and feeding results back to their health care providers to facilitate treatment 
initiation or modification.[ CE-1304-7250]
Addressing communication gaps between clinicians and patients with diabetes and providers 
is likely to improve DPN recognition and outcomes. Regardless of the method employed, 
system level interventions should aim to standardize and systematize the collection of 
patient symptom reports, as well as to improve diagnostic strategies. A key goal of the 
enhanced National CLAS Standards is to provide more specific guidance to health care 
systems in addressing the specific communication needs of vulnerable populations, 
including those who do not speak English, in order to facilitate the translation of these 
strategies across diverse care settings.41 This study found limited evidence that addressing 
communication with patients with limited English proficiency may reduce the amount of 
under-diagnosed DPN in certain subgroups of patients. Given the inability of this study to 
explain most of the differences by race/ethnicity, future studies should work toward 
elucidating and addressing the causes of those differences.
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Table 1









White 3917 (30.9) 2341 (28.4) 1576 (35.5)
Chinese 1055 (8.3) 832 (10.1) 223 (5.0)
African American 2763 (21.8) 1750 (21.2) 1013 (22.8)
Latino 3080 (24.3) 2058 (25.0) 1022 (23.0)
Filipino 1866 (14.7) 1264 (15.3) 602 (13.6)
Agegroup*
<50 2232 (17.6) 1561 (18.9) 671 (15.1)
50-64 6287 (49.6) 4001 (48.5) 2286 (51.5)
65+ 4162 (32.8) 2683 (32.5) 1479 (33.3)
Gender*
Female 6359 (50.2) 4073 (49.4) 2286 (51.3)
Male 6322 (49.9) 4172 (50.6) 2150 (48.5)
Education*
Did not graduate high
school
1857 (14.6) 1196 (14.5) 661 (14.9)
High School Graduate, no
college
3604 (28.4) 2325 (28.2) 1279 (28.8)
Some College 3331 (26.3) 2081 (25.2) 1250 (28.2)
College Graduate+ 3632 (28.6) 2468 (29.9) 1164 (26.2)
Missing 257 (2.0) 175 (2.1) 82 (1.9)
BMI (Mean (standard
deviation))*
31.5 (7.2) 31.0 (7.0) 32.3 (7.4)





9.6 (8.1) 9.0 (7.8) 10.7 (8.6)
Missing N=55 N=37 N=18
Most Recent A1c
>7.0* 5534 (43.6) 3438 (41.7) 2096 (47.3)
>9.0* 1441 (11.4) 841 (10.2) 600 (13.5)
Missing 1175 (9.3) 796 (9.7) 379 (8.5)
Any Insulin Use*
Yes 2251 (17.8) 1170 (14.2) 1081 (24.4)
No 10430 (82.3) 7075 (85.8) 3355 (75.6)























Yes 1262 (10.0) 578 (7.0) 684 (15.4)
No 8571 (67.6) 5884 (71.4) 2687 (60.6)
Missing 2848 (22.5) 1783 (21.6) 1065 (24.0)
Medicaid Insured*
Yes 177 (1.4) 83 (1.0) 94 (2.1)
No 12504 (98.6) 8162 (99.0) 4342 (97.9)
Number of outpatient
visits*
Above median† 6591 (52.0) 3975 (48.2) 2616 (59.0)




Yes 1626 (12.8) 1067 (12.9) 559 (12.6)
No 9273 (73.1) 6078 (73.7) 3195 (72.0)
Missing 1782 (14.1) 1100 (13.3) 682 (15.4)
Inadequate Health
Literacy*
Yes 2967 (23.4) 1807 (21.9) 1160 (26.2)
No 7851 (61.9) 5278 (64.0) 2573 (58.0)
Missing 1863 (14.7) 1160 (14.1) 703 (15.9)
Patient-Provider
Communication*
CAHPS score=100 4374 (34.5) 3064 (37.2) 1310 (29.5)
CAHPS score < 100 5397 (42.6) 3305 (40.1) 2092 (47.2)
Missing 2910 (23.0) 1876 (22.8) 1034 (23.3)
Discusses Pain with
Provider*
Yes 6110 (48.2) 3601 (43.7) 2509 (56.6)
No 2255 (17.8) 1605 (19.5) 650 (14.7)
MIssing 4316 (34.0) 3039 (36.9) 1277 (28.8)
Diabetic Peripheral
Neuropathy Diagnosis*
Yes 3462 (27.3) 1413 (17.1) 2049 (46.2)
No 9219 (72.7) 6832 (82.9) 2387 (53.8)
Column percents presented, but may not sum to 100 due to rounding.
*
p-value < 0.05, Chi-square test for categorical variables or F-test for continuous variables
†
Median was 8 visits during the 12 months pre-baseline period (range: 0-254).
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Table 2
Estimated Risk Ratio for Receiving a Clinical Diagnosis of Diabetic Peripheral Neuropathy among Adults 












African American 0.88 (0.81,0.96) 0.99 (0.91,1.07)
Chinese 0.53 (0.42,0.67) 0.66 (0.52,0.82)
Latino 0.72 (0.65,0.79) 0.86 (0.77,0.95)
Filipino 0.56 (0.48,0.64) 0.68 (0.59,0.78)
Age (ref < 50)
Age 50-64 1.40 (1.20,1.64) 1.27 (1.10,1.47)
Age 65+ 1.72 (1.48,2.01) 1.46 (1.27,1.71)
Male (ref = female) 0.95 (0.88,1.03) 0.97 (0.9,1.05)
Education (ref = no high school diploma)
High School Diploma 1.0 (0.88,1.14) 0.95 (0.84,1.07)
Some College 1.0 (0.88,1.14) 0.98 (0.87,1.11)
College Graduate 1.12 (0.98,1.27) 1.11 (0.98,1.25)
Covariates
Symptom frequency (ref = 1-3 times/month)
1-2 days/week 1.08 (0.91,1.28) 1.04 (0.89,1.22)
3-4 days/week 1.4 (1.20,1.64) 1.27 (1.10,1.48)
5-7 days/week 1.86 (1.64,2.11) 1.61 (1.43,1.83)
Insulin Use (ref= no) 1.47 (1.36,1.58) 1.15 (1.06,1.25)
Duration (ref = <5 years)
Duration 5-9 years 1.2 (1.05,1.36) 1.16 (1.03,1.31)
Duration 10 years or more 1.56 (1.39,1.75) 1.31 (1.17,1.47)
HbA1c >9.0 (ref ≤ 9.0) 0.99 (0.88,1.11) 1.07 (0.95,1.20)
BMI (ref-normal weight)
Underweight (<18.5) 1.38 (0.99,1.94) 1.15 (0.76,1.73)
Overweight (25-30) 0.94 (0.81,1.10) 0.94 (0.81,1.09)
Obese (>30) 1.04 (0.90,1.21) 0.99 (0.86,1.14)
Depression (ref PHQ9<10) 1.14 (1.03,1.26) 1.06 (0.98,1.15)
Medicaid (ref = no) 1.24 (1.0,1.55) 1.17 (0.97,1.41)
Above median number of outpatient visits (ref below
median)
1.63 (1.48,1.79) 1.41 (1.28,1.55)
*
Imputed missing values for all covariates
**
Partially adjusted model included all covariates except for the communication variables of interest.
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Table 3
Assessment of whether communication mediates the likelihood of Receiving a Clinical Diagnosis of Diabetic 






































































Age (ref < 50)






























Did not discuss pain
with doctor (ref =
yes)







-- -- -- -- 1.02 (0.93,1.11)
*
All models were adjusted for the same variables as in the partially-adjusted model from Table 2 (educational attainment, BMI, gender, symptom 
frequency, duration of diabetes, HbA1c>9%, depression, Medicaid status, and the number of outpatient visits). Imputed missing values for all 
covariates except the potential mediating variables (inadequate health literacy, low English language proficiency, did not discuss pain with doctor 
and poor patient-provider communication).
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